BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 6290046)

  • 1. Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells.
    Anzano MA; Roberts AB; Meyers CA; Komoriya A; Lamb LC; Smith JM; Sporn MB
    Cancer Res; 1982 Nov; 42(11):4776-8. PubMed ID: 6290046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of phorbol esters on the activity of purified transforming growth factors.
    Kraft AS
    Cancer Res; 1986 Apr; 46(4 Pt 1):1764-7. PubMed ID: 3004705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
    Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
    J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
    Salomon DS; Zwiebel JA; Noda M; Bassin RH
    J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of transforming growth factors in human breast cancer cells.
    Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR
    Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse Balb/c3T3 cell mutant with low epidermal growth factor receptor activity: induction of stable anchorage-independent growth by transforming growth factor beta.
    Kuratomi Y; Ono M; Yasutake C; Mawatari M; Kuwano M
    J Cell Physiol; 1987 Jan; 130(1):51-7. PubMed ID: 3468117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
    Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA
    Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of transforming growth factors by human colon cancer lines.
    Coffey RJ; Shipley GD; Moses HL
    Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta as a potent promoter in two-stage BALB/c 3T3 cell transformation.
    Hamel E; Katoh F; Mueller G; Birchmeier W; Yamasaki H
    Cancer Res; 1988 May; 48(10):2832-6. PubMed ID: 3258789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factors (TGFs): properties and possible mechanisms of action.
    Todaro GJ; De Larco JE; Fryling C; Johnson PA; Sporn MB
    J Supramol Struct Cell Biochem; 1981; 15(3):287-301. PubMed ID: 6267317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Growth factors produced by rat glioma cells: activities of transforming growth factors].
    Kanno H; Shinonaga M; Kuwabara T; Umeda M
    No To Shinkei; 1989 Sep; 41(9):905-9. PubMed ID: 2590559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factors from neoplastic and nonneoplastic tissues.
    Roberts AB; Frolik CA; Anzano MA; Sporn MB
    Fed Proc; 1983 Jun; 42(9):2621-6. PubMed ID: 6303865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine secretion of peptide growth factors by tumor cells.
    Todaro GJ
    Natl Cancer Inst Monogr; 1982; 60():139-47. PubMed ID: 6289103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The purification of an acid- and heat-labile transforming growth factor from an avian sarcoma virus-transformed rat cell line.
    Yamaoka K; Hirai R; Tsugita A; Mitsui H
    J Cell Physiol; 1984 Jun; 119(3):307-14. PubMed ID: 6327732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent beta-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F.
    Pircher R; Lawrence DA; Jullien P
    Cancer Res; 1984 Dec; 44(12 Pt 1):5538-43. PubMed ID: 6093998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and partial purification of a new class of transforming growth factors from an avian sarcoma virus-transformed rat cell line.
    Hirai R; Yamaoka K; Mitsui H
    Cancer Res; 1983 Dec; 43(12 Pt 1):5742-6. PubMed ID: 6315215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factors released from Kirsten sarcoma virus transformed cells do not compete for epidermal growth factor membrane receptors.
    Chua CC; Geiman D; Ladda RL
    J Cell Physiol; 1983 Oct; 117(1):116-22. PubMed ID: 6311845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor (TGF) activity in human urine: synergism between TGF-beta and urogastrone.
    Twardzik DR; Sherwin SA
    J Cell Biochem; 1985; 28(4):289-97. PubMed ID: 2997242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line.
    Korc M; Haussler CA; Trookman NS
    Cancer Res; 1987 Sep; 47(18):4909-14. PubMed ID: 3497713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of anchorage-independent growth by epidermal growth factor and altered sensitivity to type beta transforming growth factor in partially transformed rat kidney cells.
    Newman MJ; Lane EA; Nugent MA; Racker E
    Cancer Res; 1986 Nov; 46(11):5842-50. PubMed ID: 3019539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.